Intramedullary Hip Screw Market Size, Share, & Trends Analysis | Global | 2025-2031 | Includes: Titanium Intramedullary Hip Screws, and 1 more

The global intramedullary (IM) hip screw market was valued at $1.1 billion in 2024. The market is projected to grow, reaching $1.3 billion by 2031.

This report covers the full suite of products in the global IM hip screw market, including titanium and stainless-steel IM hip screws. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers and limiters, recent mergers and acquisitions, procedure trends, and technology developments. The study provides historical data to 2021 and forecasts through 2031.

Market Overview

Intramedullary hip screws have become the global standard for internal fixation of intertrochanteric and subtrochanteric fractures of the femur. Their biomechanical design provides superior stability, allowing earlier patient mobilization and improved fracture healing compared to conventional hip screw constructs. The continued shift toward intramedullary fixation reflects growing confidence among surgeons in the clinical reliability and favorable outcomes of these systems.

The global market is driven by increasing hip fracture incidence due to aging populations, particularly in North America, Europe, and parts of Asia-Pacific. Elderly patients are more prone to low-energy trauma and fragility fractures, which remain a major cause of morbidity and healthcare cost. Hospitals and trauma centers continue to prioritize devices that combine strength, reproducibility, and reduced complication rates.

Compared with plate-based fixation, IM hip screws provide enhanced rotational stability, axial load distribution, and controlled fracture impaction. These features reduce reoperation rates and postoperative complications, which supports continued adoption across developed and emerging markets.

Material composition remains a central factor in purchasing decisions. Titanium IM screws dominate the market because of their light weight, biocompatibility, and resistance to corrosion and fatigue. New titanium alloys are under development to further enhance strength and durability, reflecting ongoing R&D investment from major manufacturers. Stainless steel screws retain use in high-load cases and cost-sensitive markets but are gradually losing share as titanium systems become more affordable.

Globally, the IM hip screw market benefits from its essential role in trauma care, where procedures are non-elective and must proceed regardless of economic conditions. This dynamic stabilizes demand and limits exposure to macroeconomic downturns.

Market Drivers

Growth in Popularity of Intramedullary Screws

Over the past decade, treatment standards for proximal femoral fractures have shifted decisively from plate and conventional screw constructs toward intramedullary hip screws. These systems offer a superior combination of strength, stability, and controlled fracture compression, enabling patients to bear weight earlier and recover faster.

Although IM hip screws typically carry a higher ASP than conventional constructs, the improved clinical outcomes justify their cost. Hospitals increasingly view them as the most cost-effective option for managing intertrochanteric and subtrochanteric fractures due to reduced reoperation rates and shorter hospital stays.

This clinical preference is reinforced by continuous refinement of implant geometry, locking mechanisms, and instrumentation. Modern designs improve insertion accuracy, reduce operative time, and decrease the risk of intraoperative fracture or hardware failure. As training programs and orthopedic curricula emphasize IM fixation techniques, procedural adoption continues to rise across all regions.

Role in Essential Surgery

IM hip screws are used in non-elective surgeries that address traumatic or fragility fractures of the proximal femur. Because these procedures are urgent, demand remains steady regardless of economic cycles or changes in hospital capital budgets.

The essential nature of hip fracture treatment means that procedural volumes are closely tied to demographic factors rather than discretionary spending. As global life expectancy rises and populations age, the frequency of hip fractures is expected to increase steadily, particularly in regions with mature healthcare systems. This demographic trend underpins long-term demand stability in the IM hip screw market.

Favorable Clinical Outcomes

Clinical research consistently demonstrates that IM hip screws outperform traditional fixation methods for intertrochanteric and subtrochanteric fractures. The intramedullary placement provides a load-sharing construct that allows early mobilization, leading to improved rehabilitation and lower complication rates.

The design enables controlled sliding at the fracture site, facilitating natural compression and reducing the risk of implant failure. This biomechanical advantage explains why IM hip screws have almost completely replaced conventional hip screw systems in many hospitals worldwide. As data on reduced reoperation rates accumulate, surgeons continue to prefer IM constructs for their reliability and long-term performance.

Market Limiters

ASP Decreases

Despite stable procedural demand, ASPs for orthopedic trauma implants remain under pressure from group purchasing organizations (GPOs), government tenders, and value-based procurement initiatives. These purchasing models aggregate demand and prioritize price competition, reducing the ability of manufacturers to sustain premiums even in specialized implant categories.

Regions such as China have seen particularly steep price declines following the rollout of national procurement policies in 2021. Similar dynamics affect Western Europe and North America, where hospitals leverage collective bargaining to standardize products and negotiate volume discounts. Over time, this trend limits value growth despite consistent unit expansion.

Growth of Hip Replacement

Advances in joint reconstruction are creating indirect competition for IM hip screws. Total and partial hip replacements have become increasingly reliable, with improved implant materials, modular designs, and refined surgical techniques.

As outcomes for arthroplasty procedures improve, some surgeons prefer hip replacement over internal fixation for complex fractures, particularly in elderly patients with osteoporotic bone or poor functional prognosis. This clinical shift reduces the potential pool of candidates for IM screw fixation, particularly in tertiary care centers with high arthroplasty expertise.

Although IM screws remain the standard for most intertrochanteric fractures, the long-term trend toward greater use of hip replacements in elderly populations represents a limiting factor for growth.

Increased Surgical Complexity

While IM hip screws deliver superior mechanical results, their insertion requires greater surgical precision and experience. The entry point and trajectory must be carefully planned, and proper fracture reduction must be achieved before nail insertion. These steps add time and complexity to the operation compared to conventional hip screw systems.

Additionally, patients implanted with IM hip nails may experience postoperative thigh pain, especially when constructs use two distal locking screws or when the nail extends into the diaphysis. Although such complications are manageable, they remain a consideration when surgeons evaluate fixation options.

Training programs and improved instrumentation continue to mitigate these challenges, but surgical complexity remains a barrier to universal adoption in lower-resource hospitals.

Market Coverage and Data Scope

• Time Frame: Base year 2024, forecasts 2025-2031, and historical data 2021-2023.
• Care Settings: Hospitals, trauma centers, and orthopedic surgical facilities.
• Methodology: Market values derived from unit sales X ASP, validated through procedure volumes, hospital purchasing data, and import/export records.

Market Segmentation Summary

• Intramedullary Hip Screw Market - Further Segmented Into:
• Material Type: Stainless Steel and Titanium
• Quantitative Coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
• Qualitative Coverage: Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
• Data Sources: Primary interviews with industry leaders, regulatory and government data, hospital procurement records, and iData Research's internal database.

Competitive Analysis

Stryker

Stryker was the leading company in the global intramedullary hip screw market in 2024. The company's Gamma(R) Nail System has long been recognized for redefining the treatment of proximal femoral fractures and shifting the market away from conventional hip screws. The Gamma(R) portfolio's strong clinical record, combined with broad global availability and streamlined instrumentation, ensures continued leadership. Stryker's established relationships with trauma centers and distributors reinforce its position at the top of the market.

DePuy Synthes

DePuy Synthes ranked second globally, supported by its comprehensive product suite, including the PFNA(R), TFN(R), and TFNA(R) (Titanium Trochanteric Fixation Nail Advanced) systems. These devices are designed for reliable fixation and controlled compression in proximal femoral fractures. DePuy Synthes benefits from brand trust, extensive clinical documentation, and integration with its broader trauma portfolio, which includes plates, screws, and intramedullary systems. Continued investment in titanium-based innovations is expected to support incremental market share gains.

Smith & Nephew

Smith & Nephew held the third-largest share in the IM hip screw market, primarily through its TRIGEN INTERTAN(R) Intertrochanteric Antegrade Nail. This dual integrated screw system allows controlled fracture impaction and enhanced rotational stability. While Smith & Nephew's growth has been modest, the TRIGEN INTERTAN(R) remains a reliable and widely used system that supports a stable share position in a highly consolidated market.

Technology and Practice Trends

• Titanium Alloy Innovation: Ongoing R&D in titanium and hybrid alloys improves fatigue resistance and implant longevity.
• Shorter Nails: Shorter constructs reduce stress on the femoral shaft and lower thigh pain rates.
• Advanced Locking Options: Multidirectional locking systems enhance rotational and axial stability.
• Instrumentation Upgrades: Ergonomic targeting devices and reamers streamline procedures and reduce operating time.
• Minimally Invasive Techniques: Percutaneous approaches and improved targeting reduce tissue trauma and blood loss.
• Postoperative Pain Reduction: New designs aim to mitigate thigh pain through optimized distal locking configurations.

Methodology Appendix and Acronym Glossary included.

Why This Report

Where are the largest and fastest-growing regions within the global IM hip screw market through 2031.

How titanium innovation and material shifts are shaping product design, cost, and competitiveness.

Which companies are leading and how their portfolios compare by feature, reach, and performance.

How GPOs, tenders, and procurement models influence pricing and adoption.

How hip replacement trends are impacting fracture fixation decisions and patient management.

What design innovations reduce operative complexity and postoperative complications.

The Global Intramedullary Hip Screw Market Report from iData Research answers these questions with device-level analysis, company share tracking, and pricing benchmarks.

It enables stakeholders to quantify demand, evaluate competition, and plan commercial strategy across material and regional segments.